Network origin in Horacio Plotkin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Universidad de Buenos Aires
43
| College/University | Other Consumer Services | 43 |
| Public Company | Pharmaceuticals: Major | 20 | |
| Extinct | Biotechnology | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Horacio Plotkin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | Multi-Line Insurance | Corporate Officer/Principal Chief Investment Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| NEUROLOGIX, INC. | Internet Software/Services | Director of Finance/CFO Director/Board Member | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Director/Board Member | |
| TRANSPORTADORA DE GAS DEL SUR S.A. | Gas Distributors | General Counsel General Counsel | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
| INTEROIL EXPLORATION AND PRODUCTION ASA | Oil & Gas Production | Chairman Director/Board Member | |
| EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
| ARCOS DORADOS HOLDINGS INC. | Restaurants | Director/Board Member Director of Finance/CFO Human Resources Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| LOMA NEGRA COMPAÑÍA INDUSTRIAL ARGENTINA SOCIEDAD ANÓNIMA | Construction Materials | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree | |
| Pontificia Universidad Católica Argentina | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| Universidad del CEMA | College/University | Masters Business Admin Masters Business Admin | |
| Austral Universidad | College/University | Masters Business Admin Masters Business Admin | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Universidad Torcuato di Tella | College/University | Masters Business Admin Masters Business Admin | |
| PHARNEXT SCA | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| UCB BioSciences, Inc. | Corporate Officer/Principal | ||
Empresa Distribuidora de Electricidad de Mendoza Edemsa
 Empresa Distribuidora de Electricidad de Mendoza Edemsa Electric UtilitiesUtilities Empresa Distribuidora de Electricidad de Mendoza EDEMSA engages in the distribution of public electricity within the area. The company was founded in 11 March, 1998 and is headquartered in Mendoza, Argentina. | Electric Utilities | Director/Board Member Director of Finance/CFO | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
| McDonald's Latin America, LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| SEER, INC. | Biotechnology | Chief Executive Officer General Counsel | |
| Fundacion Loma Negra | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| Universidad Austral | College/University | Director/Board Member Graduate Degree | |
| COYA THERAPEUTICS, INC. | Biotechnology | President | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman |
Statistics
International
| United States | 31 |
| Argentina | 10 |
| Canada | 4 |
| France | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 15 |
| Utilities | 4 |
| Finance | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 196 |
| Corporate Officer/Principal | 126 |
| Chief Executive Officer | 55 |
| Independent Dir/Board Member | 51 |
| Undergraduate Degree | 50 |
Most connected contacts
| Insiders | |
|---|---|
| Carrie Cox | 22 |
| Srinivas Rao | 22 |
| John Kozarich | 21 |
| Gary Lyons | 20 |
| Cornelius E. Golding | 18 |
| Scott Myers | 18 |
| Gustavo Mahler | 16 |
| Maged Shenouda | 16 |
| Jeffrey Meckler | 15 |
| Omid Farokhzad | 15 |
| Jeff Paley | 14 |
| Diego Miralles | 14 |
| Carlos Alberto Boero Hughes | 12 |
| Martin Shkreli | 12 |
| Carlos Daniel Silva | 11 |
- Stock Market
- Insiders
- Horacio Plotkin
- Company connections
